Related Experiment Video
Updated: Aug 15, 2026

Anti-Nuclear Antibody Screening Using HEp-2 Cells
Published on: June 23, 2014
[Sneddon syndrome with anti-mitochondrial type M5 antibodies]
C Seinturier1, B Imbert, D Ponard
1Unité de médecine vasculaire 10 C, Département pluridisciplinaire de médecine, CHU de Grenoble, BP 217, 38043 La Tronche Cedex. CSeinturier@chu-grenoble.fr
Introduction:
Antimitochondrial type M5 antibodies (AMA-M5) are among the immunological abnormalities associated with Sneddon syndrome.
Case:
A 45 year-old woman, hospitalized for diplopia and with a 20-year history of obstetrical accidents, internuclear ophthalmoplegia and livedo, was diagnosed with Sneddon syndrome associated with primary antiphospholipid syndrome (APS) aggravated by the presence of AMA-M5.
Discussion:
AMA-M5 are immunological markers of APS to the same extent as antiphospholipid antibodies. This case demonstrates the interest of screening for AMA-M5 in cases of strong clinical suspicion of APS when the anticoagulant lupus test is normal and no anti-cardiolipin, anti-b2 glycoprotein I or antiprothrombin antibodies are found.
Related Concept Videos
Animal Mitochondrial Genetics
ATP Synthase: Mechanism

